| Legal ForumsRegisterSign inBankruptcyBusinessCriminalEmploymentFamilyImmigrationReal EstateMore... | ChatUpcomingArchiveHelpAsk a LawyerMost Recent Q&AAsk a QuestionAsk a Lawyer Archive |
Covidien, a leading global provider of healthcare
products, has announced that it’s tissue reinforcement
product, Duet TRS, has been
connected with the deaths of three patients who underwent chest
surgery.
Thirteen other patients have sustained serious personal injuries. For
these reasons, Covidien has issued a voluntary recall of all tissue
reinforcers in the Duet TRS product line. Philadelphia personal injury
attorneys of Messa & Associates urge patients who may affected by
this recall to contact their physicians immediately.
The manufacturer of the defective medical
device admitted
that the Duet TRS has the potential to injure adjacent anatomical
structures within the thorax, which may result in life-threatening,
post-operative complications.
The tissue reinforcement product is applied to a patient at the same
time as medical staples during chest surgeries, but should no longer be
used during those surgeries due to the risks of serious injury and
death. Covidien reported that they have sold 500,000 of the devices
since 2009.
The Philadelphia personal injury attorneys at Messa & Associates
are
experienced in handling cases involving pharmaceutical and medical
device injuries. Our extremely skilled team of personal injury attorneys
and medical experts is dedicated to ensuring you receive proper
compensation for your personal injuries. If you have been injured by a
defective medical device, a negligent medical provider, or have endured
any other type of personal injury, contact the personal injury attorneys
of Messa & Associates for a free consultation. Call toll free at
1-877-MessaLaw, or submit a free online
inquiry.
